HBV DNA / HBV DNA Suppression / Undetectable HBV DNA

Pegasys Suppresses HBV DNA More Than Lamivudine Over 3 Years - 5/04/07

Peginterferon Alfa-2a (Pegasys) plus Adefovir Is Safe and Results in Greater Reduction in ALT and HBV DNA Suppression than Pegasys Alone  - 4/27/07

Entecavir Reduces HBV DNA More than Adefovir in Chronic Hepatitis B Patients at 48 Weeks  - 4/13/07

A Case for Treating High Hepatitis B DNA Levels before Starting HIV Therapy  12/05/06

Entecavir Produces Greater HBV DNA Suppression than Adefovir or Lamivudine in Treatment-naive HBeAg Positive Patients   11/10/06

Presence of Intrahepatic HBV DNA Does Not Predict Recurrence after Liver Transplantatione 10/31/06

Entecavir is Associated with Improved Liver Histology and Reduced HBV DNA in Patients with Lamivudine-Resistant Virus- 5/30/06

HBV DNA Detection and Quantification

Telbivudine Provides Greater Antiviral and Clinical Efficacy Compared to Lamivudine in Patients with Chronic Hepatitis B - 3/31/06

Histologic Improvement in Patients with Chronic Hepatitis B after Treatment with Peginterferon alfa-2a (Pegasys) Monotherapy - 11/18/05

HBV DNA Level Predicts the Incidence of Liver Cirrhosis in Chronic HBV Infection - 5/18/05

HBV-DNA Levels at Week 12 Do Not Predict Which HBeAg-negative Patients Are Likely or Unlikely to Have a Response to Peginterferon Alfa-2a (Pegasys) Monotherapy at Week 72 - 5/09/05

HBV DNA Plasma Levels Do Matter - 4/22/05

HBV Viral Load at the Time of Liver Transplantation Determines the Risk of HBV Recurrence and Indicates the Best Prophylaxis Strategy - 3/23/05

Recommendations for Therapy of Chronic Hepatitis B Based on the Natural History of Disease in Australian Patients - 1/31/05

Treatment with Adefovir Dipivoxil 10 Mg Over 144 Weeks Results in Increasing HBeAg Loss and Seroconversion Rates and Continued Reductions in Serum HBV DNA and ALT Levels - 11/19/04

Greater HBV DNA Reductions Seen within the First Two Weeks of Therapy with Telbivudine - 11/05/04

Entecavir Is Superior to Lamivudine at Reducing HBV DNA Regardless of Baseline ALT Levels  - 11/03/04

Evaluation of Roche COBAS TaqMan Test for Quantitation of HBV DNA in Genotypes A - G 05/03/04

Treatment of Chronic HBV Patients with Adefovir Monotherapy Results in Loss of HBsAg, Undetectable HBV DNA and Normalization of ALT 04/16/04